Currently holds positions in Iveric Bio Inc and Bausch & Lomb Inc
Position | Company | Period |
---|---|---|
Director | Iveric Bio Inc | Jan. 1, 2019 - |
Executive Vice President and Chief Medical Officer | Bausch & Lomb Inc | March 1, 2011 - |
Independent Director | Alimera Sciences Inc | Jan. 1, 2003 - May 1, 2016 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-06-14 | 2022-06-13 |
Iveric Bio Inc
(ISEE)
|
B Purchase |
25,000
+333.3%
9.62240,500 USD |
25,000 +333.3% | 9.62 | 240,500 USD | |
2016-12-14 | 2016-12-12 |
Alimera Sciences Inc
(ALIM)
|
S Sale |
30,000
-31.3%
1.1133,300 USD |
30,000 -31.3% | 1.11 | 33,300 USD | |
2016-12-14 | 2016-12-12 |
Alimera Sciences Inc
(ALIM)
|
S Sale |
20,000
-20.9%
1.1122,200 USD |
20,000 -20.9% | 1.11 | 22,200 USD | |
2015-09-08 | 2015-09-03 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
200
+9.3%
3.00600 USD |
200 +9.3% | 3.00 | 600 USD | |
2015-09-08 | 2015-09-03 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
6,224
+6.5%
3.0018,672 USD |
6,224 +6.5% | 3.00 | 18,672 USD | |
2015-09-01 | 2015-08-24 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
2,150
+inf%
3.006,450 USD |
2,150 +inf% | 3.00 | 6,450 USD | |
2015-09-01 | 2015-08-24 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
6,389
+inf%
3.0019,167 USD |
6,389 +inf% | 3.00 | 19,167 USD | |
2011-03-14 | 2011-03-10 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
10,000
+100.0%
7.7577,500 USD |
10,000 +100.0% | 7.75 | 77,500 USD | |
2011-03-14 | 2011-03-10 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
10,000
+98.0%
7.7577,500 USD |
10,000 +98.0% | 7.75 | 77,500 USD | |
2011-03-14 | 2011-03-10 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
10,000
+100.0%
7.7577,500 USD |
10,000 +100.0% | 7.75 | 77,500 USD | |
2011-03-14 | 2011-02-25 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
10,000
+inf%
7.9579,500 USD |
10,000 +inf% | 7.95 | 79,500 USD | |
2011-03-14 | 2011-02-25 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
7,600
+292.3%
7.8759,824 USD |
7,600 +292.3% | 7.87 | 59,824 USD | |
2010-11-09 | 2010-11-05 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
2,600
+inf%
10.3426,884 USD |
2,600 +inf% | 10.34 | 26,884 USD | |
2010-11-09 | 2010-11-05 |
Alimera Sciences Inc
(ALIM)
|
B Purchase |
10,000
+inf%
10.50105,000 USD |
10,000 +inf% | 10.50 | 105,000 USD |